These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Long-term management of various hyperlipidemias using clofibrate]. Studlar M; Pichler O; Kindler K Wien Med Wochenschr; 1975 Dec; 125(50-52):746-51. PubMed ID: 1229130 [No Abstract] [Full Text] [Related]
27. [Clofibrate and coronary disease]. Nikkilä E Duodecim; 1972; 88(10):684-7. PubMed ID: 5068883 [No Abstract] [Full Text] [Related]
28. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia. Vecchio TJ; Linden CV; O'Connell MJ; Heilman J Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415 [TBL] [Abstract][Full Text] [Related]
29. [Effects of clofibrate, Isopharm, on fat tolerance in atherosclerotic patients]. Passowicz L Pol Tyg Lek; 1972 Jul; 27(30):1163-6. PubMed ID: 5073024 [No Abstract] [Full Text] [Related]
30. Why measure cholesterol after myocardial infarction, and when? Oliver MF Br Med J (Clin Res Ed); 1984 Dec; 289(6459):1641-2. PubMed ID: 6439355 [No Abstract] [Full Text] [Related]
31. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia]. Arntz HR; Klemens UH; Vollmar LJ; Lang PD Med Klin; 1978 Dec; 73(49):1731-7. PubMed ID: 723760 [TBL] [Abstract][Full Text] [Related]
32. Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention. Prescrire Int; 1999 Aug; 8(42):116-20. PubMed ID: 11503831 [TBL] [Abstract][Full Text] [Related]
33. [Influence of a combined treatment using clofibrate and persantin persantinat on increased serum lipid levels]. Hammerl H; Nebosis G; Pichler O; Studlar M Med Welt; 1973 Mar; 24(12):468-70. PubMed ID: 4700881 [No Abstract] [Full Text] [Related]
34. Lipid-lowering drugs. Med Lett Drugs Ther; 1975 Jun; 17(12):49-50. PubMed ID: 1128443 [No Abstract] [Full Text] [Related]
36. [Intervention study for the reduction of risk of myocardial infarct]. Stransky M; Kälin MW; Schwarzenbach FH; Schär M Osterr Krankenpflegez; 1986; 39():186-9. PubMed ID: 3638584 [No Abstract] [Full Text] [Related]
37. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia]. Carlson LA; Olsson AG; Orö L; Rössner S Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566 [No Abstract] [Full Text] [Related]
38. [Prevention of myocardial infarction by reducing serum cholesterol levels. High-risk strategies should be limited]. Jacobsen BK Tidsskr Nor Laegeforen; 1991 Jun; 111(17):2159-61. PubMed ID: 1871755 [TBL] [Abstract][Full Text] [Related]
39. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial. Eisalo A; Manninen V Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196 [No Abstract] [Full Text] [Related]
40. [Possibilities in the prevention of heart infarct]. Kutscha W Z Gesamte Inn Med; 1968 Jan; 23(1):9-13. PubMed ID: 4873961 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]